Gene expression in the adrenal glands of three spontaneously hypertensive rat substrains

Molecular Medicine Reports

Volumn 3, Issue 2, 2010, Pages 213-222

  Ashenagar, Mohammad Said ^a   Tabuchi, Masaki ^a   Kinoshita, Kosho ^a   Ooshima, Kana ^a   Niwa, Atsuko ^a   Watanabe, Yuko ^b,c   Yoshida, Momoko ^b,c   Shimada, Kazunori ^b   Yasunaga, Teruo ^c   Yamanishi, Hiromich ^b   Higashino, Hideaki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hirakataryoikuen   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Adrenal gland; Gene expression; Hypertension; Malignant spontaneously hypertensive rats; Spontaneously hypertensive rats; Stroke prone spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; APELIN; EPOXIDE HYDROLASE; GAP JUNCTION PROTEIN; KYNURENINASE; OSTEONECTIN; RGS2 PROTEIN; SOMATOMEDIN C RECEPTOR; UROTENSIN II;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE ISOLATION; GENETIC ASSOCIATION; HYPERTENSION; MALIGNANT STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; WISTAR KYOTO RAT;

RATTUS;

EID: 77950840739     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_000000242     Document Type: Article

References (36)

1. McBride MW, Charchar FJ, Graham D, et al: Functional genomics in rodent models of hypertension. J Physiol 554: 56-63, 2004.
2. Okamoto K and Aoki K: Development of a strain of spontaneously hypertensive rat. Jpn Circ J 27: 282-293, 1963.
3. Okamoto K, Yamori Y and Nagaoka A: Establishment of the stroke-prone spontaneously hypertensive rats (SHR). Circ Res 34 (Suppl 1): 143-153, 1974.
4. Okamoto K, Yamamoto K, Morita N and Ohta Y: Establishment and characteristics of rat with precocious and severe hypertension (M-SHRSP). Acta Med Kinki Univ 10: 73-95, 1985.
5. Friese RS, Mahboubi P, Mahapatra NR, et al: Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension. Am J Hypertens 18: 633-652, 2005.
6. Simon R, Lam A, Li M-C, et al: Analysis of gene expression data using BRB-array tools. Cancer Informatics 3: 11-17, 2007.
7. Altschul SF, Thomas LM, Alejandro AS, et al: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1977.
8. Tanase H, Suzuki Y, Ooshima A, et al: Genetic analysis of blood pressure in spontaneously hypertensive rats. Jpn Circ J 34: 1197-1212, 1970.
9. Yen TT, Yu PL, Roeder H and Willard PW: A genetic study of hypertension in Okamoto-Aoki spontaneously hypertensive rats. Heredity 33: 309-316, 1974.
10. Socha MJ, Manhiani M, Said N, et al: Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am J Pathol 171: 1104-1112, 2007.
11. Mizutani K, Sugimoto K, Okuda T, et al: Kynureninase is a novel candidate gene for hypertension in spontaneously hypertensive rats. Hypertens Res 25: 135-140, 2002.
12. Tang M, Wang G, Lu P, et al: Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9: 1506-1512, 2003.
13. Haefliger JA, Meda P, Formenton A, et al: Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase. Arterioscler Thromb Vasc Biol 19: 1615-1622, 1999.
14. Tsai CS, Loh SH, Liu JC, et al: Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Atherosclerosis 206: 86-94, 2009.
15. Choi MY, Romer AI, Hu M, et al: A dynamic expression survey identifies transcription factors relevant in mouse digestive tract development. Development 133: 4119-4129, 2006.
16. Lee DK, George SR and O'Dowd BF: Unravelling the role of the apelin system: prospective therapeutic applications in heart failure and obesity. Trend Pharmacol Sci 27: 190-194, 2006.
17. Cruzado MC, Risler NR, Miatello RM, et al: Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulin-like growth factor-1 receptor transactivation. Am J Hypertens 18: 81-87, 2005.
18. L opez-Ilasaca M, Liu X, Tamura K and Dzau VJ: The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell 14: 5038-5050, 2003.
19. Okamoto K, Yamamoto N, Morita Y, et al: Establishment and use of the M strain of stroke-prone spontaneously hypertensive rat. J Hypertens (Suppl 4): 21-24, 1986.
20. Nogueira EF, Vargas CA, Otis M, et al: Angiotensin-II acute regulation of rapid response genes in human, bovine and rat adrenocortical cells. J Mol Endocrinol 39: 365-374, 2007.
21. Grzeszkiewicz TM, Lindner V, Chen N, et al: The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 143: 1441-1450, 2002.
22. Wang Z, Nakayama T, Sato N, et al: The purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene associated with essential hypertension in Japanese men. J Hum Hypertens: Aug 27, 2009 (E-pub ahead of print).
23. Rose P, Bond J, Tighe S, et al: Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB and CREB. Am J Physiol Heart Circ Physiol 294: H1075-H1085, 2008.
24. Passino C, Del Ry S, Severino S, et al: C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. Eur J Cardiovasc Prev Rehabil 15: 168-172, 2008.
25. Gizard F, Robillard R, Barbier O, et al: TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1. Mol Cell Biol 25: 4335-4348, 2005.
26. Watanabe T, Arita S, Shiraishi Y, et al: Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases. Curr Med Chem 16: 550-563, 2009.
27. Monti J, Fischer J, Paskas S, et al: Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease. Nat Genet 40: 529-537, 2008.
28. Pete G, Hu Y, Walsh M, et al: Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc Soc Exp Biol Med 213: 187-192, 1996.
29. Havlik RJ: Predictors of hypertension. Population studies. Am J Hypertens 4: S586-S589, 1991.
30. Osher E, Weisinger G, Limor R, et al: The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Mol Cell Endocrinol 252: 201-206, 2006.
31. Williams RR, Hunt SC, Hasstedt SJ, et al: Multigenic human hypertension: evidence for subtypes and hope for haplotypes. J Hypertens (Suppl 8): 39-46, 1990.
32. Garver WS and Heidenreich RA: The Niemann-Pick C proteins and trafficking of cholesterol through the late endosomal/lysosomal system. Curr Mol Med 2: 485-505, 2002.
33. Hermann GE, van Meter MJ, Rood JC, et al: Proteinase-activated receptors in the nucleus of the solitary tract: evidence for glial-neural interactions in autonomic control of the stomach. J Neurosci 29: 9292-9300, 2009.
34. Nauta AJ, Daha MR, Tijsma O, et al: The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol 32: 783-792, 2002.
35. Vasa-Nicotera M, Brouilette S, Mangino M, et al: Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 76: 147-151, 2005.
36. Breuza L, Halbeisen R, Jen P, et al: Proteomics of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies ERGIC-32, a new cycling protein that interacts with human Erv46. J Biol Chem 279: 47242-47253, 2004.